Clinical trials - HealthQuill

Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.

Eli Lilly: Alzheimer’s test drug slows cognitive decline in early stages

HQ Team July 18, 2023: Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of.

by HealthQuill
July 18, 2023
0 Comments

British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy to treat older adults during a phase III stage trial.

Drugs Health Pharma

GSK’s RSV vaccine shows positive data on efficacy in older adults

HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.

by HealthQuill
June 21, 2023
0 Comments

The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer in adult patients, according to a statement.

Drugs Health Pharma

Pfizer gets FDA nod for combination drug to treat advanced prostate cancer

HQ Team June 21, 2023: The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer.

by HealthQuill
June 20, 2023
0 Comments

Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9% vaccination success rate.

Drugs Medical Pharma

France’s Valneva says trial vaccine for chikungunya post 98.9% rate

HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.

by HealthQuill
June 13, 2023
0 Comments

AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the disease, according to a company statement.

Drugs Health Medical Pharma

AstraZeneca’s drug cuts risk of lung cancer death by 51%, trials show

HQ Team June 5, 2023: AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the.

by HealthQuill
June 5, 2023
0 Comments

Pfizer Inc.’s phase III experimental therapy for treating hemophilia has shown a 92% reduction in bleeding compared to other existing cures, the US-based company stated.

Drugs Health Medical Pharma

Pfizer’s hemophilia trial cure shows 92% cut in bleeds

Pfizer’s hemophilia trial cure shows a 92% cut in bleeds HQ Team May 30, 2023: Pfizer Inc.’s phase III experimental therapy for treating.

by HealthQuill
May 31, 2023
0 Comments

Human trials to stop radioactive contaminants begin

Drugs Health Medical Pharma

Human trials to stop radioactive contaminants in body begin

HQ Team May 17, 2023: The first trial on humans of an experimental oral drug for removing radioactive contaminants from inside the body.

by HealthQuill
May 17, 2023
0 Comments

SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk and immunocompromised patients.

Drugs Medical Pharma

SAB gets FDA fast track nod for experimental drug to treat influenza

HQ Team April 14, 2023: SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk.

by HealthQuill
April 14, 2023
0 Comments

Scientists are close to developing a human treatment for nonalcoholic fatty liver after they successfully developed a compound tested in non-human primates.

Drugs Health Pharma

Cure for nonalcoholic fatty liver disease may be near: Scientists say

HQ Team April 11, 2023: Scientists are close to developing a human treatment for nonalcoholic fatty liver after successfully developing a compound tested.